CHAPTER 01 Executive Summary
1.1 Digital Biomarkers Market Snapshot
1.2 Digital Biomarkers Market- Key Findings
CHAPTER 02 Market Landscape
2.1 Market Definition
2.2 Market Scope and Segmentation
2.3 Key Players
2.3.1 INDUSTRY PLAYERS
2.4 Industry Trends
2.4.1 HEALTHCARE TRENDS
2.4.2 TECHNOLOGY TRENDS
2.4.3 MACROECONOMIC TRENDS
2.5 Opportunities and Challenges in the Digital Biomarker Space
2.5.1 UTILIZING SMARTPHONE-BASED OBJECTIVE MEASUREMENTS OF PHYSICAL FUNCTION
2.5.2 SOFTWARE AS A MEDICAL DEVICE (SAMD) AND AI
2.5.3 POSTOPERATIVE CARE
2.5.4 VOICE AND AUDIO MEASUREMENTS
2.5.5 SWEAT ANALYTICS
2.5.6 OBJECTIVE MEASUREMENTS IN NEUROLOGY
2.6 Cardiovascular and Metabolic Disease (CVMD)
CHAPTER 03 Digital Biomarkers Value Chain
3.1 Value Chain Analysis
3.1.1 FUNCTIONS OF DIGITAL BIOMARKERS
3.2 Devices for Measuring Digital Biomarkers
3.2.1 DEVICE LAYER - SENSORS
3.2.2 PORTABLE DEVICES
3.2.3 WEARABLE DEVICES
3.2.4 APP LAYER
CHAPTER 04 Digital Biomarkers Industry Analysis
4.1 Digital Biomarkers Market Structure - PORTER’s Analysis
4.2 Deals in Digital Biomarkers
4.3 Funding in Digital Biomarkers
4.4 Partnerships in the Digital Biomarkers
4.5 Timeline of Digital Biomarkers
4.6 Digital Biomarkers Case Studies
4.6.1 ROCHE: ONE OF THE LEADING BIOPHARMACEUTICAL COMPANIES IN THE DIGITAL BIOMARKER SPACE IN NEUROLOGY
4.6.2 HEARTLINE: APPLE AND JOHNSON & JOHNSON PAVE THE WAY DIGITIZING CLINICAL TRIALS IN CVD
4.6.3 FDA APPROVAL OF RESPIRATORY BIOMARKERS
4.6.4 INNOVATION CHALLENGES TO ENCOURAGE COLLABORATION AND NEW SOLUTIONS
4.6.5 DIGITAL BIOMARKERS HAVE THE POTENTIAL TO TRANSFORM THE DIAGNOSIS OF MENTAL HEALTH
CHAPTER 05 Global Digital Biomarkers Revenue Opportunity
5.1 Global Digital Biomarkers Market
5.2 COVID-19 Pandemic
5.2.1 USING DIGITAL BIOMARKERS TO MITIGATE THE IMPACT OF COVID 19 ON CLINICAL TRIALS
CHAPTER 06 Regulatory Overview
6.1 Regulatory Scenario
6.1.1 US
6.1.2 CANADA
6.1.3 EUROPE
6.1.4 ASIA-PACIFIC
6.1.5 REGULATORY TRENDS
CHAPTER 07 Digital Biomarkers Type Outlook
7.1 Digital Biomarkers - Type Dive
7.1.1 MONITORING DIGITAL BIOMARKERS
7.1.2 DIAGNOSTICS DIGITAL BIOMARKERS
7.1.3 PREDICTIVE DIGITAL BIOMARKERS
7.1.4 OTHERS
CHAPTER 08 Digital Biomarkers in Product Type Outlook
8.1 Digital Biomarkers - Product Type Deep Dive
8.1.1 WEARABLE APPLICATIONS
8.1.2 MOBILE APPLICATIONS
8.1.3 PORTABLES
CHAPTER 09 Digital Biomarkers in Therapeutic Area Outlook
9.1.1 NEUROLOGICAL AND MENTAL HEALTH
9.1.2 CARDIOVASCULAR
9.1.3 RESPIRATORY
9.1.4 DIABETIC
9.1.5 OTHERS
CHAPTER 010 Digital Biomarkers End-User Outlook
10.1 Digital Biomarkers - End-User Deep Dive
10.1.1 HEALTHCARE COMPANIES
10.1.2 HEALTHCARE PROVIDERS
10.1.3 OTHERS
CHAPTER 011 Digital Biomarkers Regional Outlook
11.1 Digital Biomarkers - Regional Deep Dive
11.1.1 NORTH AMERICA
11.1.2 EUROPE
11.1.3 ASIA-PACIFIC
11.1.4 ROW
CHAPTER 012 Trends, Drivers, and Challenges
12.1 Digital Biomarkers - Market Trends
12.1.1 DIGITAL BIOMARKERS HAVE EMERGED AS IMPORTANT PREDICTIVE TOOLS TO SUPPORT THE GLOBAL COVID-19 PANDEMIC
12.1.2 DEVELOPMENT OF AI-BASED DIGITAL BIOMARKERS
12.1.3 DIGITAL BIOMARKERS AS AN EMERGING TOOL FOR PRECISION MEDICINE
12.1.4 GROWING TECHNOLOGY INNOVATIONS
12.2 Digital Biomarkers - Market Drivers
12.2.1 AGING POPULATION AND RISE IN CHRONIC DISEASES
12.2.2 INCREASING INVESTMENTS AND FUNDING TO DEVELOP DIGITAL BIOMARKERS
12.2.3 INCREASE IN M&A AND PARTNERSHIPS TO BOOST THE ADOPTION OF DIGITAL BIOMARKERS
12.2.4 INCREASING ROLE OF DIGITAL BIOMARKERS IN CLINICAL TRIALS
12.3 Digital Biomarkers - Market Challenges
12.3.1 CHALLENGE TO MAINTAIN DATA SECURITY
12.3.2 DATA STANDARDIZATION AND INTERPRETATION ISSUES
12.3.3 DIFFICULTIES IN VALIDATION OF BIOMARKERS
CHAPTER 013 Digital Biomarkers Competitive LandscapeCHAPTER 014 Digital Biomarkers Vendor Snapshot
14.1.1 COMPANY SNAPSHOT: ACTIGRAPH, LLC
14.1.2 COMPANY SNAPSHOT: ALIVECOR, INC.
14.1.3 COMPANY SNAPSHOT: BIOGEN INC.
14.1.4 COMPANY SNAPSHOT: AKILI INTERACTIVE LABS INC.
14.1.5 COMPANY SNAPSHOT: EMBIC CORP.
14.1.6 COMPANY SNAPSHOT: FITBIT
14.1.7 COMPANY SNAPSHOT: HAPPIFY HEALTH
14.1.8 COMPANY SNAPSHOT: HUMA
14.1.9 COMPANY SNAPSHOT: IXICO PLC
14.1.10 KONEKSA
14.1.11 MINDSTRONG HEALTH
14.1.12 WINTERLIGHT LABS
14.1.13 CLARIO
14.1.14 IMAGENE AI
14.1.15 BRAINOMIX
14.1.16 KINSA INC.
14.1.17 FEEL THERAPEUTICS
CHAPTER 015 Appendix
15.1 Methodology
15.2 About US
List of Tables
Table 1 Key Trends Overview
Table 2 Research Scope and Segmentation
Table 3 The Leaders in Digital Biomarkers
Table 4 Healthcare Trends
Table 5 Technology Trends
Table 6 Macroeconomic Trends
Table 7 Different Uses of Digital Biomarkers
Table 8 M&A in Digital Biomarkers
Table 9 Funding Activity in the Digital Biomarkers Industry
Table 10 Partnership Activity in the Digital Biomarkers Industry
Table 11 Digital Biomarkers Market
Table 12 Fig.11 Digital Biomarkers by Type, 2020-2027 ($Mn)
Table 13 Fig.26 Digital Biomarkers by Product Type, 2020-2027 ($Mn)
Table 14 Fig. Fig.31 Digital Biomarkers by Therapeutic Area, 2020-2027 ($Mn)
Table 15 Fig.39 Digital Biomarkers by End-User, 2020-2027 ($Mn)
Table 16 Digital Biomarkers by Region, 2020-2027 ($Mn)
Table 17 North America Digital Biomarkers by Country, 2020-2027 ($Mn)
Table 18 Europe Digital Biomarkers by Country, 2020-2027 ($Mn)
Table 19 Asia-Pacific Digital Biomarkers by Country, 2020-2027 ($Mn)
Table 20 Technology Innovations by Digital Biomarker Companies
Table 21 Competitive Position of Leading Companies
List of Figures
Figure 1 Market Snapshot ($Mn)
Figure 2 Key Segment Performance Snapshot
Figure 3 Leaders and Challengers in Digital Biomarker Space
Figure 4 Digital Biomarker Value Chain
Figure 5 Different Device Sensors and Functions
Figure 6 Different Device Sensors and Functions
Figure 7 Digital Biomarker Value Chain
Figure 8 Leaders and Challengers in Wearable Technology
Figure 9 Digital Biomarker Value Chain
Figure 10 Digital Biomarker Value Chain
Figure 11 Examples of Skin Patches/Sensors
Figure 12 Examples of Skin Patches/Sensors
Figure 13 Summary of Ingestible Technologies
Figure 14 Examples of Mobile Apps that Can Be Used to Collect Digital Biomarkers
Figure 15 Examples of Companies Developing Software for the Collection and Analysis of Digital Biomarkers
Figure 16 Global Digital Biomarkers PORTER’s Five Force Analysis
Figure 17 Timeline of Digital Biomarkers
Figure 18 Global Digital Biomarkers Market - Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 19 Key Findings
Figure 20 Digital Biomarkers by Type- Market Overview ($Mn)
Figure 21 Digital Biomarkers by Type - 2021 & 2027 (%)
Figure 22 Monitoring Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 23 Diagnostics Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 24 Predictive Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 25 Other Types of Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 26 Digital Biomarkers by Product Type- Market Overview ($Mn)
Figure 27 Digital Biomarkers by Product Type Share - 2021 & 2027 (%)
Figure 28 Wearable Applications Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 29 Mobile Applications Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 30 Portables Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 31 Digital Biomarkers by Therapeutic Area- Market Overview ($Mn)
Figure 32 Digital Biomarkers by Therapeutic Area Share - 2021 & 2027 (%)
Figure 33 Neurological and Mental Health Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 34 Cardiovascular Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 35 Respiratory Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 36 Diabetic Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 37 Others Applications Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 38 Digital Biomarkers by End-User - Market Overview ($Mn)
Figure 39 Digital Biomarkers by End-User Share - 2021 & 2027 (%)
Figure 40 Healthcare Companies Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 41 Healthcare Providers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 42 Others Digital Biomarkers End-User Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 43 Digital Biomarkers by Region- Market Overview ($Mn)
Figure 44 Digital Biomarkers by Region Share - 2021 & 2027 (%)
Figure 45 North America Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 46 Europe Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 47 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 48 ROW Market Revenue Opportunity Forecast, 2020-2027 ($Mn)